Loading market dashboard
AC Immune S.A.
ACIUHealthcareNASDAQCH
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
AC Immune S.A. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $117.28M | $93.93M - $155.53M | -$70.37M | $0.398 | 1 |
| Dec 2029 | $108.13M | $86.60M - $143.40M | -$64.88M | $0.363 | 2 |
| Dec 2028 | $117.84M | $94.38M - $156.27M | -$70.70M | $0.489 | 3 |
| Dec 2027 | $91.76M | $73.49M - $121.68M | -$55.05M | $0.206 | 2 |
| Dec 2026 | $31.67M | $25.37M - $42.00M | -$19.00M | -$0.344 | 2 |
| Dec 2025 | $4.34M | $3.49M - $5.19M | -$2.60M | -$0.606 | 3 |
| Dec 2024 | $27.09M | $26.89M - $27.38M | -$16.25M | -$0.537 | 3 |
| Dec 2023 | $13.93M | $11.16M - $18.48M | -$8.36M | -$0.588 | 2 |
| Dec 2022 | $5.58M | $1.34M - $13.60M | -$3.35M | -$0.875 | 1 |
| Dec 2021 | $28.25M | $6.80M - $68.82M | -$16.95M | -$0.632 | 1 |
| Dec 2020 | $15.63M | $3.76M - $38.07M | -$9.38M | -$0.826 | 1 |
| Dec 2019 | $112.82M | $27.14M - $274.81M | -$67.69M | $0.685 | 1 |